Curt Hartman, Interim Chief Executive Officer at CONMED Corporation (NASDAQ:CNMD), bought 10,000 shares of Common Stock, directly, yesterday, paying a…
Browsing: BioTech
Allergan, Inc. (NYSE:AGN) has filed a case to sue Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Bill Ackman’s fund, Pershing Square,…
United Therapeutics Corporation (NASDAQ:UTHR)’s President and Chief Operating Officer, Roger Jeffs, reported a stock disposition of 50,000 shares in Common…
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) saw three of its insiders complete stock dispositions on Friday. S&R Technology Holdings, LLC, one of…
United Therapeutics Corporation (NASDAQ:UTHR) saw two of its insiders unload stock last week. The company’s Chief Executive Officer, Martine Rothblatt,…
Genome sequencing technology maker Illumina, Inc. (NASDAQ:ILMN) posted a record second quarter revenue of $448 million, beating estimates of $427…
Gilead Sciences, Inc. (NASDAQ:GILD) is not trending up in the stock market even though they have reported impressive numbers, Meg…
On Monday, Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) saw one of its largest shareholders acquires the vast amount of 1,625,436 shares of…
United Therapeutics Corporation (NASDAQ:UTHR) saw two of its insiders complete dispositions last Thursday. The talk is of John Maxim Ferrari,…
Robert Flanagan, Director at Sagent Pharmaceuticals Inc. (NASDAQ:SGNT), completed a stock disposition of 16,000 shares on Friday. The Common Stock…
Accelerate Diagnostics Inc. (NASDAQ:AXDX) saw two of its insiders purchase the company’s stock this week. Larry Feinberg, 10% owner of…
David Thompson, Vice President and General Counsel at MannKind Corporation (NASDAQ:MNKD), sold 30,000 shares of Common Stock, $0.01 Par Value…